AMEX:MLSS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. More Details


Snowflake Analysis

Excellent balance sheet with limited growth.

Share Price & News

How has Milestone Scientific's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MLSS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-6.7%

MLSS

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

68.7%

MLSS

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: MLSS exceeded the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: MLSS exceeded the US Market which returned 13.8% over the past year.


Shareholder returns

MLSSIndustryMarket
7 Day-6.7%-1.7%-0.8%
30 Day-12.0%-3.5%-5.7%
90 Day-28.2%12.2%8.6%
1 Year68.7%68.7%17.5%16.5%16.4%13.8%
3 Year7.7%7.7%70.0%65.6%36.9%27.8%
5 Year-56.1%-56.1%139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is Milestone Scientific's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Milestone Scientific undervalued compared to its fair value and its price relative to the market?

5.19x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate MLSS's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate MLSS's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: MLSS is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: MLSS is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate MLSS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: MLSS is overvalued based on its PB Ratio (5.2x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Milestone Scientific forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

8.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MLSS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MLSS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MLSS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MLSS's revenue (22.5% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: MLSS's revenue (22.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if MLSS's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Milestone Scientific performed over the past 5 years?

-10.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MLSS is currently unprofitable.

Growing Profit Margin: MLSS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MLSS is unprofitable, and losses have increased over the past 5 years at a rate of 10.2% per year.

Accelerating Growth: Unable to compare MLSS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MLSS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).


Return on Equity

High ROE: MLSS has a negative Return on Equity (-62.03%), as it is currently unprofitable.


Next Steps

Financial Health

How is Milestone Scientific's financial position?


Financial Position Analysis

Short Term Liabilities: MLSS's short term assets ($19.9M) exceed its short term liabilities ($3.4M).

Long Term Liabilities: MLSS's short term assets ($19.9M) exceed its long term liabilities ($627.0K).


Debt to Equity History and Analysis

Debt Level: MLSS's debt to equity ratio (1.6%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if MLSS's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MLSS has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: MLSS has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 9% each year.


Next Steps

Dividend

What is Milestone Scientific current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MLSS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MLSS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MLSS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MLSS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MLSS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.9yrs

Average management tenure


CEO

Leonard Osser (73 yo)

2.75yrs

Tenure

US$691,302

Compensation

Mr. Leonard A. Osser has been the Interim Chief Executive Officer of Milestone Scientific Inc., since December 18, 2017 and serves as its Director of China Operations. Mr. Osser is a Founder of Milestone S ...


CEO Compensation Analysis

Compensation vs Market: Leonard's total compensation ($USD691.30K) is about average for companies of similar size in the US market ($USD604.44K).

Compensation vs Earnings: Leonard's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Leonard Osser
Founder2.75yrsUS$691.30k3.72%
$ 3.4m
Joseph D'Agostino
Chief Financial Officer12.67yrsUS$403.24k1.39%
$ 1.3m
Jan Haverhals
Presidentno datano datano data
James McAvinn
Senior Vice President of Sales & Marketing3.92yrsno datano data
Rosaline Shau
Vice President and Assistant Controllerno datano datano data

3.9yrs

Average Tenure

68yo

Average Age

Experienced Management: MLSS's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Leonard Osser
Founder2.75yrsUS$691.30k3.72%
$ 3.4m
Neal Goldman
Independent Director1.42yrsUS$36.00k1.86%
$ 1.7m
Leonard Schiller
Independent Director23.42yrsUS$36.00k0.41%
$ 381.7k
Paul Davis
Member of Scientific Advisory Boardno datano datano data
Ralf Gebhard
Member of Scientific Advisory Boardno datano datano data
Lorrence Green
Member of Scientific Advisory Boardno datano datano data
Gian Trombetta
Director6.33yrsUS$280.00k0%
$ 0
Michael McGeehan
Independent Director2.92yrsUS$36.00k0.24%
$ 219.4k
Olivier Choquet
Member of Scientific Advisory Boardno datano datano data

6.3yrs

Average Tenure

73yo

Average Age

Experienced Board: MLSS's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: MLSS insiders have sold more shares than they have bought in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 38.7%.


Top Shareholders

Company Information

Milestone Scientific Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Milestone Scientific Inc.
  • Ticker: MLSS
  • Exchange: AMEX
  • Founded: 1989
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$92.217m
  • Shares outstanding: 65.87m
  • Website: https://www.milestonescientific.com

Number of Employees


Location

  • Milestone Scientific Inc.
  • 220 South Orange Avenue
  • Livingston
  • New Jersey
  • 7039
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MLSSAMEX (NYSE MKT LLC)YesCommon StockUSUSDNov 1995

Biography

Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/28 05:03
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.